This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
REGENXBIO Inc. is a biotechnology company whose core business involves the development of gene therapies. This research and development process is dependent on animal testing to meet regulatory requirements for safety and efficacy. The company’s pipeline of potential treatments is built on preclinical data generated from animal models, a standard industry practice that constitutes commercial exploitation of animals under this exclusion category.
The evidence gathered pertains to securities litigation and regulatory risk disclosures, not to the company's animal testing practices. This indicates a significant evidence gap regarding the specific scale, nature, or documented controversies of REGENXBIO's animal testing operations. Without direct evidence of the company's animal use, this exclusion is based on the standard operational model of preclinical biotech development.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.